Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans

Journal of Clinical Oncology

Volumn 20, Issue 17, 2002, Pages 3586-3591

  Rubin, Brian P ^a   Schuetze, Scott M ^a   Eary, Janet F ^a   Norwood, Thomas H ^a   Mirza, Sohail ^a   Conrad, Ernest U ^a   Bruckner, James D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMATINIB; METHYLPREDNISOLONE; PLATELET DERIVED GROWTH FACTOR B; PROTEIN TYROSINE KINASE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CASE REPORT; DERMATOFIBROSARCOMA PROTUBERANS; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; DERMATOFIBROSARCOMA; HUMANS; MALE; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-SIS; PYRIMIDINES; SKIN NEOPLASMS; SPINAL CORD NEOPLASMS;

EID: 0036727124     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.01.027     Document Type: Article

References (18)

1. Fibrohistiocytic tumors of intermediate malignancy
2. Dermatofibrosarcoma protuberans: An analysis of 86 cases - Five with metastasis
3. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: Clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance
4. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34
5. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma
6. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas
7. Dermatofibrosarcoma protuberans harboring t(9;22)(q32;q12.2)
8. The dermatofibrosarcoma protuberans-associated collagen type Ialphal/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB
9. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
10. Effect of the tyrosine kinase inhibitor STI 571 in a patient with a metastatic gastrointestinal stromal tumor
11. STI571: Targeting BCR-ABL as therapy for CML
12. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans
13. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI 571 through induction of apoptosis
14. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: A phase I study
15. Chromosomal changes in a dedifferentiated chondrosarcoma: A case report and review of the literature
16. Radiation in management of patients with dermatofibrosarcoma protuberans
17. Dermatofibrosarcoma protuberans: Treatment and prognosis
18. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma